Annual EBITDA
-$10.50 M
+$4.40 M+29.52%
31 December 2022
Summary:
Histogen annual earnings before interest, taxes, depreciation & amortization is currently -$10.50 million, with the most recent change of +$4.40 million (+29.52%) on 31 December 2022. During the last 3 years, it has risen by +$8.15 million (+43.70%). HSTO annual EBITDA is now -1036.69% below its all-time high of -$924.00 thousand, reached on 31 December 2019.HSTO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$3.83 M
-$1.78 M-86.83%
30 September 2023
Summary:
Histogen quarterly earnings before interest, taxes, depreciation & amortization is currently -$3.83 million, with the most recent change of -$1.78 million (-86.83%) on 30 September 2023. HSTO quarterly EBITDA is now -487.42% below its all-time high of -$652.00 thousand, reached on 31 March 2022.HSTO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$12.25 M
-$269.00 K-2.25%
30 September 2023
Summary:
Histogen TTM earnings before interest, taxes, depreciation & amortization is currently -$12.25 million, with the most recent change of -$269.00 thousand (-2.25%) on 30 September 2023. HSTO TTM EBITDA is now -620.78% below its all-time high of -$1.70 million, reached on 30 June 2019.HSTO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HSTO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +43.7% | -0.0% | +45.1% |
| 5 y5 years | - | -123.6% | -258.9% |
HSTO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +43.7% | -487.4% | at low | -16.6% | +45.1% |
| 5 y | 5 years | -1036.7% | +43.7% | -487.4% | +63.6% | -258.9% | +45.1% |
| alltime | all time | -1036.7% | +43.7% | -487.4% | +63.6% | -620.8% | +45.1% |
Histogen EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$3.83 M(+86.8%) | -$12.25 M(+2.2%) |
| June 2023 | - | -$2.05 M(-40.3%) | -$11.98 M(-9.9%) |
| Mar 2023 | - | -$3.44 M(+17.3%) | -$13.29 M(+26.5%) |
| Dec 2022 | -$10.50 M(-29.5%) | -$2.93 M(-17.7%) | -$10.50 M(-1.9%) |
| Sept 2022 | - | -$3.56 M(+6.0%) | -$10.70 M(-2.4%) |
| June 2022 | - | -$3.36 M(+415.3%) | -$10.97 M(-3.0%) |
| Mar 2022 | - | -$652.00 K(-79.2%) | -$11.30 M(-24.1%) |
| Dec 2021 | -$14.90 M | -$3.13 M(-18.3%) | -$14.90 M(-33.2%) |
| Sept 2021 | - | -$3.83 M(+3.6%) | -$22.30 M(+2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$3.69 M(-13.1%) | -$21.79 M(+3.4%) |
| Mar 2021 | - | -$4.25 M(-59.6%) | -$21.08 M(+13.0%) |
| Dec 2020 | -$18.66 M(+1918.9%) | -$10.52 M(+216.7%) | -$18.66 M(+75.6%) |
| Sept 2020 | - | -$3.32 M(+11.4%) | -$10.62 M(+17.9%) |
| June 2020 | - | -$2.98 M(+63.4%) | -$9.01 M(+16.6%) |
| Mar 2020 | - | -$1.83 M(-26.7%) | -$7.73 M(+30.9%) |
| Dec 2019 | -$924.00 K | -$2.49 M(+45.4%) | -$5.90 M(+73.0%) |
| Sept 2019 | - | -$1.71 M(+0.8%) | -$3.41 M(+100.8%) |
| June 2019 | - | -$1.70 M | -$1.70 M |
FAQ
- What is Histogen annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Histogen?
- What is Histogen quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Histogen?
- What is Histogen TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Histogen?
What is Histogen annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of HSTO is -$10.50 M
What is the all time high annual EBITDA for Histogen?
Histogen all-time high annual earnings before interest, taxes, depreciation & amortization is -$924.00 K
What is Histogen quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of HSTO is -$3.83 M
What is the all time high quarterly EBITDA for Histogen?
Histogen all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$652.00 K
What is Histogen TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of HSTO is -$12.25 M
What is the all time high TTM EBITDA for Histogen?
Histogen all-time high TTM earnings before interest, taxes, depreciation & amortization is -$1.70 M